This webinar will review the regulatory requirements for investigating an OOS Investigation. The responsibilities of the analyst, the supervisor and QA will be discussed. A detailed flow chart will be used to help the attendees clearly understand the steps and the order in which they are to be performed. The structure of an Investigation report which properly documents the investigation will be discussed.
WHY SHOULD YOU ATTEND?
The lack of or Inadequate procedures for handling out of specification (OOS) situations and failure investigations are amongst the most frequently found deviations in FDA warning letters.
Most companies have procedures but either they are not adequate or are not followed. This seminar will guide attendees through the entire process from detection an out-of-specification result to informal and formal laboratory and batch investigations.
AREA COVERED
- Phase I- Laboratory Phase of Investigations
- Phase II a Full Scale Investigation
- Concluding an Investigation
- Out-of Trend investigations
- Common pitfalls during OOS Investigations
- Review of recent OOS related citations in Warning Letters
LEARNING OBJECTIVES
- Benefits: The lack of or Inadequate procedures for handling out of specification (OOS) situations and failure investigations are amongst the most frequently found deviations in FDA warning letters.
- Most companies have procedures but either they are not adequate or are not followed. This seminar will guide attendees through the entire process from detection an out-of-specification result to informal and formal laboratory and batch investigations.
- Complimentary Hand-outs (other than ppt slides): For e.g. checklists, process documents, flow charts, pdf or docs of supplementary reading material, etc.
WHO WILL BENEFIT?
- Quality Assurance/Quality Control Directors, Managers, and Specialists
- Regulatory Affairs/Regulatory Compliance Directors, Managers, and Specialists
- Quality Control Laboratory Staff
The lack of or Inadequate procedures for handling out of specification (OOS) situations and failure investigations are amongst the most frequently found deviations in FDA warning letters.
Most companies have procedures but either they are not adequate or are not followed. This seminar will guide attendees through the entire process from detection an out-of-specification result to informal and formal laboratory and batch investigations.
- Phase I- Laboratory Phase of Investigations
- Phase II a Full Scale Investigation
- Concluding an Investigation
- Out-of Trend investigations
- Common pitfalls during OOS Investigations
- Review of recent OOS related citations in Warning Letters
- Benefits: The lack of or Inadequate procedures for handling out of specification (OOS) situations and failure investigations are amongst the most frequently found deviations in FDA warning letters.
- Most companies have procedures but either they are not adequate or are not followed. This seminar will guide attendees through the entire process from detection an out-of-specification result to informal and formal laboratory and batch investigations.
- Complimentary Hand-outs (other than ppt slides): For e.g. checklists, process documents, flow charts, pdf or docs of supplementary reading material, etc.
- Quality Assurance/Quality Control Directors, Managers, and Specialists
- Regulatory Affairs/Regulatory Compliance Directors, Managers, and Specialists
- Quality Control Laboratory Staff
Speaker Profile

Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she …
Upcoming Webinars

Project Management for Human Resources Professionals

Risk Analysis in the Medical Device Design Process


Strategic Interviewing & Selection: Getting the Right Talen…

Conflict Resolution in a Remote Workplace

EEO-1 Reporting Deadline is December 5, 2023 – Now is the t…

Bootcamp for New Managers and Supervisors: Avoid These 7 Mi…

2-Hour Virtual Seminar on How to Conduct an Internal Harass…

Workplace Investigations 101: How to Conduct your Investiga…

Cleanroom, Microbiology and Sterility Assurance Practices f…

Successfully Negotiating the Labor Agreement

Understanding the incredible uses and fallbacks of ChatGPT

Wage And Hour Laws: Ensuring Compliance With The Fair Labor…

5 Key Components of Good Manufacturing Practices to obtain …

How to Manage Conflict in the Workplace

Neutralizing Harassment - How to Promote the Proactive Pers…

Changing Behavior: Why Rewards and Punishments Often Aren't…

Hybrid Workplace: 10 Best Practices to Manage Your Team’s P…

Human Error Reduction Techniques for Floor Supervisors


Using Better Managerial Decision Making - to get great resu…

Using Stay Interviews To Improve Employee Retention & Engag…

Excel - Pivot Tables - The Key To Modern Data Analysis and …

Form W-9 Compliance to Avoid Penalties: TIN Verification, B…


Using High-Performance Coaching for Managers to Address Per…


FDA Technology Modernization Action Plan (TMAP) and Impact …

FDA Audit Best Practices - Do's and Don'ts


Become an excellent Critical Thinker to greatly improve you…

Stay Interviews: A Powerful and Low-Cost Employee Engagemen…

Learn the Do's and Don'ts of Opening Business Bank Accounts


Project Management for HR, Administrative Professionals, an…